The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target

Por Wei, Jun, Marangoni, Roberta G., Fang, Feng, Wang, Wenxia, Huang, Jingang, Distler, Joerg H.W., Varga, John
Publicado no Oncotarget (2017)

The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy

Por Fang, Feng, Liu, Lei, Yang, Yang, Tamaki, Zenshiro, Wei, Jun, Marangoni, Roberta G, Bhattacharyya, Swati, Summer, Ross S, Ye, Boping, Varga, John
Publicado em 2012

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target

Por Marangoni, Roberta G., Masui, Yuri, Fang, Feng, Korman, Benjamin, Lord, Gabriel, Lee, Junghwa, Lakota, Katja, Wei, Jun, Scherer, Philipp E., Otvos, Laszlo, Yamauchi, Toshimasa, Kubota, Naoto, Kadowaki, Takashi, Asano, Yoshihide, Sato, Shinichi, Tourtellotte, Warren G., Varga, John
Publicado no Sci Rep (2017)